News
NH Tech Alliance Names the Breast Cancer Locator as Product of the Year
CairnSurgical wins NH Product of the Year.
MedTech Strategist highlights CairnSurgical
CairnSurgical: Patient-Specific, Real-Time Guidance for Breast Cancer Surgery
CairnSurgical Announces First Patient Treated in Pivotal Clinical Trial of Breast Cancer Locator System
The first patient has been treated in the pivotal clinical trial using the Breast Cancer Locator (BCL) for surgical guidance at Massachusetts General Hospital.
CairnSurgical Completes Series A investment
Celdara Medical announced that the first DRIVEN Accelerator Hub Company, CairnSurgical, Inc., has closed a Series A investment led by Morningside Group. Click to read more.
Publications
- Byrd, BK, Krishnaswamy, V, Gui, J, Rooney, T, Zuurbier, R, Rosenkranz, K et al.. The shape of breast cancer. Breast Cancer Res Treat. 2020;183 (2):403-410. doi: 10.1007/s10549-020-05780-6. PubMed PMID:32656723 PubMed Central PMC8256655.
- Barth, RJ Jr, Krishnaswamy, V, Paulsen, KD, Rooney, TB, Wells, WA, Angeles, CV et al.. A Randomized Prospective Trial of Supine MRI-Guided Versus Wire-Localized Lumpectomy for Breast Cancer. Ann Surg Oncol. 2019;26 (10):3099-3108. doi: 10.1245/s10434-019-07531-4. PubMed PMID:31359283 .
- Barth, RJ Jr, Krishnaswamy, V, Paulsen, KD, Rooney, TB, Wells, WA, Rizzo, E et al.. A Patient-Specific 3D-Printed Form Accurately Transfers Supine MRI-Derived Tumor Localization Information to Guide Breast-Conserving Surgery. Ann Surg Oncol. 2017;24 (10):2950-2956. doi: 10.1245/s10434-017-5979-z. PubMed PMID:28766199 PubMed Central PMC6015768.